 "Divi's Labs reports 13% jump in net profit at Rs 557 cr in Q1")
Drug maker Divi's Laboratories on Saturday posted a 13 per cent increase in its consolidated net profit at Rs 557 crore for the first quarter ended June 30, 2021.
The company had reported a net profit of Rs 492 crore in the April-June quarter of the previous fiscal.
Total income rose to Rs 1,997 crore in the first quarter as compared with Rs 1,748 crore in the June quarter of 2020-21 fiscal, Divi's Laboratories said in a regulatory filing.
Forex gain for the current quarter stood at Rs 20 crore as against a gain of Rs 5 crore during the corresponding quarter of the last year, it added.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app